Using fMRI to quantify the time dependence of remifentanil analgesia in the human brain.
about
Single subject pharmacological-MRI (phMRI) study: modulation of brain activity of psoriatic arthritis pain by cyclooxygenase-2 inhibitor.Investigation of cross-species translatability of pharmacological MRI in awake nonhuman primate - a buprenorphine challenge studyThe Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations.Imaging opioid analgesia in the human brain and its potential relevance for understanding opioid use in chronic pain.Brain imaging and functional gastrointestinal disorders: has it helped our understanding?From nociception to pain perception: imaging the spinal and supraspinal pathways.Imaging the Respiratory Effects of Opioids in the Human Brain.Biomarkers, designs, and interpretations of resting-state fMRI in translational pharmacological research: A review of state-of-the-Art, challenges, and opportunities for studying brain chemistry.Breaking down the barriers: fMRI applications in pain, analgesia and analgesics.Opioid suppression of conditioned anticipatory brain responses to breathlessness.Separating slow BOLD from non-BOLD baseline drifts using multi-echo fMRI.The brain in chronic pain: clinical implications.Dissociable influences of opiates and expectations on pain.Baseline reward circuitry activity and trait reward responsiveness predict expression of opioid analgesia in healthy subjects.Role of neuroimaging in analgesic drug development.The effect of intravenous lidocaine on brain activation during non-noxious and acute noxious stimulation of the forepaw: a functional magnetic resonance imaging study in the rat.Change point estimation in multi-subject fMRI studies.Neuroimaging as a tool for pain diagnosis and analgesic development.Opioid modulation of resting-state anterior cingulate cortex functional connectivity.Functional magnetic resonance imaging is a powerful approach to probing the mechanism of action of therapeutic drugs that act on the central nervous system.The brain signature of paracetamol in healthy volunteers: a double-blind randomized trial.Pharmacological functional MRI assessment of the effect of ibuprofen-arginine in painful conditions.Effects of remifentanil on processing of auditory stimuli: a combined MEG/EEG study.Polymorphism in the µ-opioid receptor gene (OPRM1) modulates neural processing of physical pain, social rejection and error processing.Effects of gabapentin on brain hyperactivity related to pain and sleep disturbance under a neuropathic pain-like state using fMRI and brain wave analysis.fMRI in analgesic drug discovery.Noninvasive brain imaging for experimental medicine in drug discovery.The role of fMRI in drug development.A short, robust brain activation control task optimised for pharmacological fMRI studiesClinical Applications of Functional Magnetic Resonance Imaging
P2860
Q24812118-78B7DFAB-EEA6-4507-8493-C9F7489BB60AQ28543992-6886E068-39C8-49A7-B39D-4CC503D71CC4Q30235485-C5DA1FC1-D190-4B74-80AE-E304EAFC44FFQ30657653-B421875C-DE7F-4706-A70F-2BEB69EFAD4AQ30942661-3CDCD7FC-A3E2-4BCD-9881-5DDCB7FF604AQ30993936-9714F1CB-0958-47CF-BC21-598949C437EDQ31110579-9DD38DAF-E15A-41A3-B23E-CD5B0E0514C7Q31158600-EA583107-290D-4CB6-AF89-8196935340ABQ33257909-4511B7D0-5093-433B-846E-9164B4F1A18BQ33565769-6065FB77-6217-4CD0-81D0-DA823FBF217CQ34674669-EFD1D572-4BA2-4AF9-BE8F-3B78D0C8DAADQ35580854-0BA83E9D-276A-4EA0-8EB5-A86DC3563540Q36070260-ECA5025D-4283-42DE-A1CF-C43E018F268FQ36378370-76C11758-6B70-4397-9E2B-542B60120B2FQ37036818-C9776C17-C3F7-4BF1-934D-1C1A35C5557FQ37189423-BC0AD8CC-DAD4-4B23-A7C9-9F0F2C9B1E2EQ41376317-4F8E3A6C-3508-4131-9A12-A77FABF7F126Q41604419-5AF78B44-D1AB-424E-A546-D6DD4DD6148FQ41689363-D0917076-00B8-4F45-AA09-4ACEE7761C37Q42399174-DE89D973-67CA-4FC6-9447-DDFE275B59F5Q42399177-230158D8-8B5C-4642-9181-A4FC51808FB7Q42860245-E15BC49F-104E-4218-9670-8D2C696AC7F1Q43732498-3E262409-537F-442B-A24A-677C01B42025Q44329864-AD23E7F1-7797-4A29-86D3-6B80C80A4E57Q48326813-14502569-93EF-4D59-B390-113264FB77A1Q48333479-C67C2AC1-2F36-4EAC-9667-B351468EDEACQ48483635-8CF911D7-DAD3-4B7E-9E1B-603A627C3097Q49873690-3BABA326-17C4-453E-A0A8-645AD7864037Q57158595-ACFA2019-FBA5-4038-BF10-2F4BC53F5DEFQ57655393-C122C00B-2C4F-4226-BD22-F1859CFD2AF2
P2860
Using fMRI to quantify the time dependence of remifentanil analgesia in the human brain.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Using fMRI to quantify the time dependence of remifentanil analgesia in the human brain.
@en
Using fMRI to quantify the time dependence of remifentanil analgesia in the human brain.
@nl
type
label
Using fMRI to quantify the time dependence of remifentanil analgesia in the human brain.
@en
Using fMRI to quantify the time dependence of remifentanil analgesia in the human brain.
@nl
prefLabel
Using fMRI to quantify the time dependence of remifentanil analgesia in the human brain.
@en
Using fMRI to quantify the time dependence of remifentanil analgesia in the human brain.
@nl
P2860
P356
P1476
Using fMRI to quantify the time dependence of remifentanil analgesia in the human brain.
@en
P2093
Irene Tracey
Pauline Williams
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300364
P407
P577
2004-03-01T00:00:00Z